Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$113.38B
Total volume
BTC 49.93%     ETH 15.33%
Dominance

Abbott Laboratories 0Q15.IL Stock

113.8 USD {{ price }} 0.388146% {{change_pct}}%
Exchange
IOB
Market Cap
197.48B USD
LOW - HIGH [24H]
112.98 - 113.91 USD
VOLUME [24H]
1.86M USD
{{ volume }}
P/E Ratio
38.83
Earnings per share
2.93 USD

Abbott Laboratories Price Chart

Abbott Laboratories 0Q15.IL Financial and Trading Overview

Abbott Laboratories stock price 113.8 USD
Previous Close 104.23 USD
Open 0 USD
Bid 0 USD x N/A
Ask 0 USD x N/A
Day's Range 104.23 - 104.23 USD
52 Week Range 93.36 - 115.37 USD
Volume 370 USD
Avg. Volume 39.17K USD
Market Cap 181.25B USD
Beta (5Y Monthly) 0.663028
PE Ratio (TTM) 31.972084
EPS (TTM) 2.93 USD
Forward Dividend & Yield 2.04 (2.00%)
Ex-Dividend Date July 13, 2023
1y Target Est N/A

0Q15.IL Valuation Measures

Enterprise Value 188.36B USD
Trailing P/E 31.972084
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.36692
Price/Book (mrq) 4.8972883
Enterprise Value/Revenue 4.538
Enterprise Value/EBITDA 17.57

Trading Information

Abbott Laboratories Stock Price History

Beta (5Y Monthly) 0.663028
52-Week Change 0.68%
S&P500 52-Week Change 20.43%
52 Week High 115.37 USD
52 Week Low 93.36 USD
50-Day Moving Average 106.31 USD
200-Day Moving Average 104.77 USD

0Q15.IL Share Statistics

Avg. Volume (3 month) 39.17K USD
Avg. Daily Volume (10-Days) 41.76K USD
Shares Outstanding 1.74B
Float 1.73B
Short Ratio N/A
% Held by Insiders 0.54%
% Held by Institutions 76.05%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.96
Trailing Annual Dividend Yield 1.88%
5 Year Average Dividend Yield 154.00%
Payout Ratio 0.5836
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 13.98%
Operating Margin (ttm) 18.00%
Gross Margin 55.63%
EBITDA Margin 25.83%

Management Effectiveness

Return on Assets (ttm) 6.31%
Return on Equity (ttm) 15.93%

Income Statement

Revenue (ttm) 41.51B USD
Revenue Per Share (ttm) 23.75 USD
Quarterly Revenue Growth (yoy) -18.099%
Gross Profit (ttm) 24.58B USD
EBITDA 10.72B USD
Net Income Avi to Common (ttm) 5.78B USD
Diluted EPS (ttm) 3.26
Quarterly Earnings Growth (yoy) -46.10%

Balance Sheet

Total Cash (mrq) 9.53B USD
Total Cash Per Share (mrq) 5.48 USD
Total Debt (mrq) 17.03B USD
Total Debt/Equity (mrq) 45.73 USD
Current Ratio (mrq) 1.678
Book Value Per Share (mrq) 21.283

Cash Flow Statement

Operating Cash Flow (ttm) 8.66B USD
Levered Free Cash Flow (ttm) 6.41B USD

Profile of Abbott Laboratories

Country United Kingdom
State IL
City North Chicago
Address 100 Abbott Park Road
ZIP 60064-6400
Phone 224 667 6100
Website https://www.abbott.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 115000

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Q&A For Abbott Laboratories Stock

What is a current 0Q15.IL stock price?

Abbott Laboratories 0Q15.IL stock price today per share is 113.8 USD.

How to purchase Abbott Laboratories stock?

You can buy 0Q15.IL shares on the IOB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Abbott Laboratories?

The stock symbol or ticker of Abbott Laboratories is 0Q15.IL.

Which industry does the Abbott Laboratories company belong to?

The Abbott Laboratories industry is Medical Devices.

How many shares does Abbott Laboratories have in circulation?

The max supply of Abbott Laboratories shares is 1.74B.

What is Abbott Laboratories Price to Earnings Ratio (PE Ratio)?

Abbott Laboratories PE Ratio is 38.83959200 now.

What was Abbott Laboratories earnings per share over the trailing 12 months (TTM)?

Abbott Laboratories EPS is 2.93 USD over the trailing 12 months.

Which sector does the Abbott Laboratories company belong to?

The Abbott Laboratories sector is Healthcare.